SCHEMBL5259231

SCHEMBL5259231

c1ccc(COc2ccc3[nH]cc(C(c4ccccc4)N4CCCC4)c3c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 2/20 0.50
KDM4E B2RXH2 1/20 0.50
MAPT P10636 1/20 0.50
LTA4H P09960 3/20 0.49
PLA2G2A P14555 3/20 0.49
HTR1D P28221 5/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
HSP90AA1 P07900 1/20 0.47
HSP90AB1 P08238 1/20 0.47
ACHE P22303 1/20 0.46
SLC6A4 P31645 1/20 0.46
POLB P06746 1/20 0.45
HRH3 Q9Y5N1 1/20 0.43
IMPDH2 P12268 1/20 0.43
HTR1A P08908 2/20 0.42
HTR1B P28222 2/20 0.42
GAA P10253 1/20 0.42
GPR55 Q9Y2T6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5261272 0.99 TRPM8 (0.49) TRPM8KDM4EMAPTLTA4HPLA2G2A
SCHEMBL5257577 0.87 LTA4H (0.46) TRPM8KDM4EMAPTLTA4HPLA2G2A
SCHEMBL7085697 0.78 TRPM8 (0.60) TRPM8KDM4EMAPTLTA4HPLA2G2A
SCHEMBL5260086 0.77 GPR84 (0.47) KDM4EMAPTMEN1KMT2ASLC6A4
SCHEMBL5260125 0.76 HTR1D (0.58) TRPM8KDM4EMAPTLTA4HPLA2G2A
SCHEMBL5261760 0.76 GPR84 (0.46) KDM4EMAPTMEN1KMT2ASLC6A4
SCHEMBL27493815 0.76 TRPM8 (0.52) TRPM8KDM4EMAPTLTA4HPLA2G2A
SCHEMBL19234918 0.76 TRPM8 (0.57) TRPM8KDM4EMAPTLTA4HPLA2G2A
SCHEMBL38657787 0.74 HTR1D (0.61) TRPM8KDM4EMAPTLTA4HPLA2G2A
SCHEMBL28273019 0.74 TRPM8 (0.58) TRPM8KDM4EMAPTLTA4HPLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1261585-B1 SUBSTITUTED INDOLE MANNICH BASES GRUENENTHAL GMBH (DE) 2007-09-26 EP claimed
US-7091220-B2 Substituted indole Mannich bases GRUENENTHAL GMBH (DE) 2006-08-15 US claimed
EP-1261585-B1 SUBSTITUTED INDOLE MANNICH BASES GRUENENTHAL GMBH (DE) 2007-09-26 EP disclosed
US-7091220-B2 Substituted indole Mannich bases GRUENENTHAL GMBH (DE) 2006-08-15 US disclosed
CN-1219763-C Substituted indole mannich bases GRUENENTHAL GMBH (DE) 2005-09-21 CN disclosed
CN-1413192-A Substituted indole mannich bases GRUENENTHAL GMBH (DE) 2003-04-23 CN disclosed
US-20030060497-A1 Subtituted indole mannich bases GRUENENTHAL GMBH (DE) 2003-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030060497-A1 Subtituted indole mannich bases TPH1, IDO1, TPH2 TRPM8 915/4885KDM4E 3011/4885MAPT 2635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.